DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 94 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactResults

BALAXI PHARMACEUTICALS LIMITED — Board Meeting Intimation

NSE 1 hr ago·27 Oct 2026, 11:50 am

Balaxi Pharma

Balaxi Pharmaceuticals has announced a board meeting scheduled for November 12, 2026. The primary agenda for this meeting is to consider and approve the company's unaudited half-yearly financial results for the period ending September 2026. Additionally, the board may discuss other business items during this session.

For investors, this announcement is a standard corporate update that provides an early look into the company's financial health for the first half of the fiscal year. The release of these results will offer insights into the company's operational performance and profitability during this period. Investors should wait for the official release of the financial statements to assess the company's trajectory accurately.